We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MASI
951
DELISTED
Masimo
MASI
| $2.65M | 0.01% |
18,215
+226
| +1% | +$43.4K |
|
952
Ashland
ASH
$3.23B
| $2.64M | 0.01% |
26,867
-2,793
| -9% | -$268K |
|
|
BDXB
953
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $2.64M | 0.01% |
50,000
| – | – |
|
954
Myers Industries
MYE
$1.16B
| $2.63M | 0.01% |
122,012
| – | – |
|
|
PENG
955
Penguin Solutions Inc
PENG
$2.47B
| $2.63M | 0.01% |
101,790
+64,264
| +171% | +$1.81M |
|
956
Visteon
VC
$2.6B
| $2.62M | 0.01% |
24,032
-4,266
| -15% | -$464K |
|
957
RingCentral
RNG
$6.14B
| $2.61M | 0.01% |
+22,283
| New | +$3.28M |
|
958
Brinker International
EAT
$8.8B
| $2.6M | 0.01% |
68,194
+68,193
| +6,819,300% | +$2.55M |
|
959
Lyell Immunopharma
LYEL
$264M
| $2.59M | 0.01% |
25,660
+15,385
| +150% | +$1.86M |
|
960
NOV
NOV
$7.33B
| $2.58M | 0.01% |
131,540
-10,141
| -7% | -$178K |
|
961
Deckers Outdoor
DECK
$10.6B
| $2.58M | 0.01% |
56,484
+26,082
| +86% | +$1.29M |
|
962
Vistra
VST
$47.1B
| $2.56M | 0.01% |
110,360
-66,800
| -38% | -$1.48M |
|
963
LyondellBasell Industries
LYB
$21B
| $2.56M | 0.01% |
24,907
-19,344
| -44% | -$1.93M |
|
964
Quince Therapeutics
QNCX
$27.6M
| $2.56M | 0.01% |
2,068
+1,537
| +289% | +$2.09M |
|
965
MacroGenics
MGNX
$260M
| $2.56M | 0.01% |
+290,458
| New | +$3.21M |
|
966
NextCure
NXTC
$27.6M
| $2.55M | 0.01% |
43,798
+3
| +0% | +$188 |
|
967
Enphase Energy
ENPH
$4.7B
| $2.55M | 0.01% |
12,640
-10,925
| -46% | -$1.72M |
|
968
Roper Technologies
ROP
$37.2B
| $2.55M | 0.01% |
5,399
-62,536
| -92% | -$28.1M |
|
969
WSFS Financial
WSFS
$4.07B
| $2.55M | 0.01% |
54,658
+13,463
| +33% | +$698K |
|
970
Progressive
PGR
$126B
| $2.55M | 0.01% |
22,330
+1,660
| +8% | +$180K |
|
971
Casella Waste Systems
CWST
$5.73B
| $2.54M | 0.01% |
28,971
+5,301
| +22% | +$422K |
|
972
Old National Bancorp
ONB
$9.68B
| $2.54M | 0.01% |
154,856
+66,273
| +75% | +$1.21M |
|
973
Nexstar Media Group
NXST
$5.04B
| $2.52M | 0.01% |
13,342
-59,866
| -82% | -$10.4M |
|
974
Regeneron Pharmaceuticals
REGN
$79.7B
| $2.51M | 0.01% |
3,600
-55
| -2% | -$34.8K |
|
975
Louisiana-Pacific
LPX
$4.57B
| $2.49M | 0.01% |
40,130
+113
| +0.3% | +$7.79K |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.